Studies in preparation and partner work on the Vitruvian Shield platform. No study result is claimed.
Each entry states its status: in preparation, letter of interest, or deployed and tested.
An observational oncology eSurvey study with clinical investigators at ULS Coimbra, prepared through the TEF-Health facility operated by Instituto Pedro Nunes, using EORTC QLQ-C30 and PRO-CTCAE on the Vitruvian Shield platform. Hosting and ethics arrangements are in preparation.
A single-site decentralised study protocol, version 2.0, prepared with ULS Santa Maria in Lisbon under the TB4Health test-bed programme, combining a wrist-worn research wearable, a dry-electrode EEG headband and camera-based vital signs during video visits. Ethics submission is targeted before the end of 2026; the principal investigator will be named on publication authorisation.
Coimbra investigators signed a non-binding letter of interest on 2 September 2026 for use of the platform in a future multiple sclerosis study.
The platform was deployed and tested with a neurology team at CHUV; fixes were delivered in April 2026 and re-engagement is planned.
Principal investigator names and participant numbers are published on authorisation.
